Abbott Laboratories (Singapore) Private Limited — China drug registrations and re-registration deadlines
5 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2027-04-17.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20160193 | Luvox 马来酸氟伏沙明片 | 2027-10-17 | 2027-04-17 |
| 国药准字HJ20181117 | Luvox 马来酸氟伏沙明片 | 2027-10-17 | 2027-04-17 |
| 国药准字HJ20160416 | Klacid 克拉霉素干混悬剂 | 2028-07-12 | 2028-01-12 |
| 国药准字HJ20160339 | Rytmonorm 盐酸普罗帕酮片 | 2029-06-30 | 2028-12-30 |
| 国药准字HJ20171365 | Lipanthyl 非诺贝特片（III） | 2030-10-19 | 2030-04-19 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.